Clinical management and infection prevention and control for mpox: living guideline, May 2025

Zusammenfassung

Clinical management and infection prevention and control for mpox Living guideline May 2025 Clinical management and infection prevention and control for mpox Living guideline May 2025 © World Health Organization 2025 Some rights reserved. This work is available under the Creative Commons Attribution- NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo ). Under the terms of this licence, you may copy, red

Kerninformationen

ng. To purchase WHO publications, see https://www.who.int/publications/book-orders . To submit requests for commercial use and queries on rights and licensing, see https://www.who.int/copyright. Third-party materials. If you wish to reuse material from this work that is attributed to a third p...

............................................................... xviii 1.1 Clinical question: What are the clinical and IPC interventions to use in caring for patients with mpox? ...........................................................................................................................

oms ............................................................................................................................ 4 2.3.1 Severe disease and complications ................................................................................. 6 2.4 Laboratory findings .......................

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen